📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting. (2018)

First Author: Rotolo A

Attributed to: Imperial Confidence in Concept: ICiC5 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ccell.2018.08.017

PubMed Identifier: 30300581

Publication URI: http://europepmc.org/abstract/MED/30300581

Type: Journal Article/Review

Volume: 34

Parent Publication: Cancer cell

Issue: 4

ISSN: 1535-6108